Viswanathan Sivakumar

8PUBLICATIONS
27CO-AUTHORS
AutoimmunityMolecular targetsInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 02, 2024
Interleukin-11 causes alveolar type 2 cell dysfunction and prevents alveolar regeneration.

Benjamin Ng, Kevin Y Huang, Chee Jian Pua

|Dec 05, 2022
Targeting endogenous kidney regeneration using anti-IL11 therapy in acute and chronic models of kidney disease.

Anissa A Widjaja, Sivakumar Viswanathan, Shamini G Shekeran

|Aug 26, 2022
IL11 Stimulates IL33 Expression and Proinflammatory Fibroblast Activation across Tissues.

Anissa A Widjaja, Sonia Chothani, Sivakumar Viswanathan

|Apr 12, 2022
IL11 Activates Pancreatic Stellate Cells and Causes Pancreatic Inflammation, Fibrosis and Atrophy in a Mouse Model of Pancreatitis.

Benjamin Ng, Sivakumar Viswanathan, Anissa A Widjaja

|Feb 10, 2022
A Neutralizing IL-11 Antibody Improves Renal Function and Increases Lifespan in a Mouse Model of Alport Syndrome.

Anissa A Widjaja, Shamini G Shekeran, Eleonora Adami

|Jun 16, 2021
Loss of Yap/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function.

Masum M Mia, Dasan Mary Cibi, Siti Aishah Binte Abdul Ghani

Pageof 2